2 transcripts
ADAP
Earnings call transcript
NASDAQ
2024 Q2
12 Aug 24
investment in manufacturing, the demonstrable clinical benefit exhibited throughout development and incredible execution of the regulatory process
ADAP
Earnings call transcript
NASDAQ
2024 Q1
15 May 24
a broad range of tumors. And then taking cell therapies into other spaces where patients can benefit in other non-oncology indications in the long
- Prev
- 1
- Next